Elefant Dov

CIK 00013264874 companiesSUWANEE, GA

SEC Profile

Transactions

Companies

Filings

CIK

0001326487

Recent Transactions

23 trades

Discretionary Transaction
FEMASYS INC$FEMY
Series B-1 Warrants
2025-11-07+34,122→ 34,122 total
Discretionary Transaction
FEMASYS INC$FEMY
Series A-1 Warrants
2025-11-07+34,122→ 34,122 total
Discretionary Transaction
FEMASYS INC$FEMY
Series C-1 Warrants
2025-11-07+34,122→ 34,122 total
Discretionary Transaction
FEMASYS INC$FEMY
Senior Secured Convertible Notes
2025-11-07
Discretionary Transaction
FEMASYS INC$FEMY
Common Warrants (right to buy)
2025-08-27+38,828→ 38,828 total
Discretionary Transaction
FEMASYS INC$FEMY
Common Stock
2025-08-27+38,828→ 58,436 total
Discretionary Transaction
FEMASYS INC$FEMY
Common Stock
2025-06-02$1.02/sh+19,608→ 19,608 total
Award
FEMASYS INC$FEMY
Stock Option (Right to Buy)
2025-01-28+114,300→ 114,300 total
Award
FEMASYS INC$FEMY
Stock Option (Right to Buy)
2025-01-28+72,045→ 72,045 total
Award
FEMASYS INC$FEMY
Stock Option (Right to Buy)
2024-02-01+84,000→ 84,000 total
Award
FEMASYS INC$FEMY
Stock Option (Right to Buy)
2023-07-03+204,700→ 204,700 total
Award
FEMASYS INC$FEMY
Stock Option (Right to Buy)
2023-07-03+105,200→ 105,200 total
Award
FEMASYS INC$FEMY
Stock Option (Right to Buy)
2022-02-28+100,000→ 100,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2022-01-25+422,000→ 422,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2021-03-04+430,000→ 430,000 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock
2020-12-28$1.35/sh+7,407→ 11,755 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Series H Warrants
2020-06-05$0.01/sh+2,174→ 2,174 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock
2020-06-05$1.15/sh+4,348→ 4,348 total
Award
Cellectar Biosciences, Inc.$CLRB
Common stock
2020-02-03$2.71/sh+10,000→ 10,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock Option (right to buy)
2020-02-03+10,000→ 10,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock Option (right to buy)
2019-09-10+90,000→ 90,000 total
Award
Akari Therapeutics Plc$AKTX
Options to Purchase Ordinary Shares
2015-09-21+4,067,963→ 4,067,963 total
Award
IMMUNE PHARMACEUTICALS INC
Stock Option (right to buy)
2006-01-05+28,125→ 28,125 total

Companies

Recent Filings

Address

C/O FEMASYS INC. 3950 JOHNS CREEK COURT, SUITE 100

SUWANEE, GA, 30024

View on SEC.gov